http://rdf.ncbi.nlm.nih.gov/pubchem/patent/DE-102010007243-A1
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_612de918cefdc4d3e391d6df84c81a7d |
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2800-52 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-5011 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-50 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-02 |
| filingDate | 2010-02-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1f126504bd8fb746af25e62e9d0262e4 |
| publicationDate | 2011-08-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | DE-102010007243-A1 |
| titleOfInvention | Therapy Optimization in Cancer Patients by Testing Therapy Combinations by In Vitro Testing (Additive) |
| abstract | At present, there is no diagnostic tool that can evaluate different treatment options for a patient in a test system. In particular, the influences of different nutrient offers and oxygen offers (modified by nutrition or medication) on a chemotherapeutic treatment with cytostatics can not yet be assessed diagnostically. By using a functional test system that observes live tumor cells in vitro, these effects can be evaluated. In particular, by the reduction or omission of glucose and / or oxygen, this can be achieved in the functional test systems. This method can be used throughout oncology. |
| priorityDate | 2010-02-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 31.